A diagnostic test for measuring Cancer Antigen 19-9 (CA19-9) levels in blood samples. This test is used in clinical laboratories for cancer screening and monitoring, particularly for gastrointestinal cancers.
Manufactured by
Espoo, Finland
Medix Biochemica is a market leading in vitro diagnostics raw material supplier with Finnish roots and global branches. We produce and supply high-quality antibodies, antigens and other critical IVD raw materials to enable our IVD customers to manufacture diagnostic tests and supporting materials all around the world. Our expertise covers market segments ranging from immunoassay, clinical chemistry and molecular diagnostics and capabilities include biospecimen accruals and contract manufacturing. With the most comprehensive raw material portfolio in the IVD world, and a team made up of the best minds in the business, we re ready to shorten your time to market and build quality into every one of your tests. Across disciplines and disease areas, whatever you need, chances are we IVDo that.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Nanjing Poclight Biotechnology Co.,Ltd.
China · 5 relevant products
VEDALAB SAS
France · 10 relevant products
J. Mitra & Co. Pvt. Ltd.
India · 1 relevant product
Boditech Med Inc.
South Korea · 7 relevant products
Institute of Isotopes Co. Ltd.
Hungary · 1 relevant product
MedLevensohn
Brazil · 3 relevant products
Fujirebio Diagnostics,Inc.
China · 5 relevant products
Zhejiang Orient Gene Biotech Co.,Ltd.
China · 4 relevant products
STRATEC/Diatron
Germany · 1 relevant product
Atlas Link, Inc.
United States · 1 relevant product
32 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 83 closest product alternatives
Nanjing Poclight Biotechnology Co.,Ltd. · China
An in vitro quantitative test kit using homogeneous chemiluminescence immunoassay for determination of Carbohydrate Antigen 19-9 in human serum and plasma. The test is used as an aid in the diagnosis of pancreatic cancer. For professional and laboratory use only, with 18 months shelf life and storage at 2-30°C without cold chain requirement.
VEDALAB SAS · France
Immunochromatographic rapid test for the quantitative determination of Cancer Antigen 19-9 (CA 19-9) in whole blood, serum or plasma. Measuring range: 30–1000 U/mL. Reading time: 15 minutes.
J. Mitra & Co. Pvt. Ltd. · India
Tumor marker assay kit for CA19-9 detection using chemiluminescence immunoassay. Analytical sensitivity of 1.50 U/mL with linearity from 1.50 to 1000 U/mL.
VEDALAB SAS · France
Immunochromatographic rapid test for the quantitative determination of Cancer Antigen 19-9 (CA 19-9) in whole blood, serum or plasma. Measuring range: 30-1000 U/mL. Reading time: 15 minutes.
VEDALAB SAS · France
Immunochromatographic rapid test for the quantitative determination of Cancer Antigen 15-3 (CA 15-3) in whole blood, serum or plasma. Measuring range: 5–200 IU/mL. Reading time: 10 minutes.
Boditech Med Inc. · South Korea
A diagnostic test reagent that supports the diagnosis of pancreatic cancer.
Institute of Isotopes Co. Ltd. · Hungary
CA19-9 is a tumour associated mucin-type high molecular weight glycoprotein antigen circulating in the blood and can be found in tissues. This test is useful in monitoring patients with confirmed pancreatic cancer whose CA19-9 levels are above the cut off at the time of the diagnosis. Patients negative for the Lewis blood group antigen have no CA 19-9 in their blood even in the presence of malignant disease.
MedLevensohn · Brazil
A rapid diagnostic test for detecting CA15-3 antigen, a tumor marker commonly used in breast cancer monitoring and diagnosis.
Fujirebio Diagnostics,Inc. · China
In vitro diagnostic assay for cancer antigen 125 detection in patient samples. The test is used for endometrial cancer evaluation and monitoring of ovarian malignancies.
Zhejiang Orient Gene Biotech Co.,Ltd. · China
Diagnostic test for detection of carcinoembryonic antigen. Supports monitoring of colorectal cancer and other malignancies.
Nanjing Poclight Biotechnology Co.,Ltd. · China
A homogeneous chemiluminescence immunoassay test kit for quantitative detection of CA125 tumor marker in human serum. Used for oncology screening and monitoring in clinical laboratory settings.
VEDALAB SAS · France
Immunochromatographic rapid test for the quantitative detection of CA 125 (ovarian cancer antigen) in whole blood, serum or plasma. Measuring range: 15–750 U/mL. Reading time: 15 minutes.
71 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products